Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Gacovetug, an antibody targeting F4+ ETEC (Veterinary Application).

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Bulumtatug, an antibody targeting LAG-3.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Birinkibart, an antibody targeting CSF2RB.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Armocibart, an antibody targeting TFPI.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Amtabafusp, an antibody targeting CD3E.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Alpitatug, an antibody targeting KLK2.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Trinbelimab, an antibody targeting RhD.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Rolistobart, an antibody targeting LILRB4.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Oloctinebart, an antibody targeting LGALS3.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Lunaxafusp, an antibody targeting HER2.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Eglatoprutug, an antibody targeting KIT.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Zeleciment, an antibody targeting TFRC.